+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Statin treatment non-adherence and discontinuation: clinical implications and potential solutions



Statin treatment non-adherence and discontinuation: clinical implications and potential solutions



Current Pharmaceutical Design 20(40): 6314-6324



Statins are the most powerful lipid lowering drugs in clinical practice. However, the efficacy of statin therapy, as seen in randomized control trials, is undermined by the documented non-adherence observed in clinical practice. Understanding the clinical consequences of statin non-adherence is an important step in implementing successful interventions aimed at improving adherence. Our previous systematic review included a literature search up to January 2010 on the effects of statin non-adherence or discontinuation on cardiovascular (CV) and cerebrovascular outcomes. We provide an update to this publication and a review of promising interventions that have reported a demonstrated improvement in statin adherence. Through a systematic literature search of PubMed, Ovid Medline, Ovid Embase, CINAHL, Cochrane Library and Web of Science, out of the 3440 initially identified, 13 studies were selected. Non-adherence in a primary prevention population was associated with a graded increase in CV risk. Individuals taking statins for secondary prevention were at particular risk when taking statin with highly variable adherence. Moreover, particular attention is warranted for non-adherence in diabetic and rheumatoid arthritis populations, as non-adherence is significantly associated with CV risk as early as 1 month following discontinuation. Statin adherence, therefore, represents an important modifiable risk factor. Numerous interventions to improve adherence have shown promise, including copayment reduction, automatic reminders, mail-order pharmacies, counseling with a health professional, and fixed-dose combination therapy. Given the complexity of causes underlying statin non-adherence, successful strategies will likely need to be tailored to each patient.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055911354

Download citation: RISBibTeXText

PMID: 24953391


Related references

Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event. American Journal of Cardiology 114(6): 826-831, 2014

Predictors of Statin Adherence, Switching, and Discontinuation in the USAGE Survey Understanding Statin Use in America and Gaps in Patient Education. Journal of Clinical Lipidology 7(3): 245-246, 2013

Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study). Turk Kardiyoloji Dernegi Arsivi 44(1): 53-64, 2016

Novel mechanistic and clinical implications concerning the safety of statin discontinuation. Pharmacological Reports 63(4): 867-879, 2011

Statin non-adherence: clinical consequences and proposed solutions. F1000research 5:, 2016

Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation. Biofactors 25(1-4): 147-152, 2005

Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. Journal of General Internal Medicine 19(6): 638-645, 2004

The effects of reduced copayments on discontinuation and adherence failure to statin medication in Australia. Health Policy 119(5): 620-627, 2015

Real Clinical Significance of Statin Cessation After Adjustment for Smoking Persistence and Antiplatelet Treatment Discontinuation. Journal of the American College of Cardiology 70(5): 684-685, 2017

Prevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With Dementia. American Journal of Alzheimer's Disease and other Dementias 33(8): 527-534, 2018

Examining prescriber perceptions of statin therapy and the potential implications these perceptions may have on guideline adherence. International Clinical Psychopharmacology 33(5): 290-296, 2018

Adherence to statin treatment: an important issue in clinical practice. Current Medical Research and Opinion 32(10): 1639-1640, 2016

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education. Journal of Clinical Lipidology 7(5): 472-483, 2014

Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clinical Cardiology 37(11): 653-659, 2015

It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All-Cause Mortality. Journal of the American Heart Association 8(7): E011378, 2019